Biomarkers in Liver Disease

There are numerous types of liver disease that may be due to toxic agents (such as alcohol or drugs), infectious agents including viruses, congenital conditions and even poor dietary patterns. It has been suggested that there are over 100 different types.  As the consequences of liver failure can be...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Patel, Vinood B. (Editor, http://id.loc.gov/vocabulary/relators/edt), Preedy, Victor R. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 2017.
Edition:1st ed. 2017.
Series:Biomarkers in Disease: Methods, Discoveries and Applications,
Subjects:
Online Access:https://doi.org/10.1007/978-94-007-7675-3
LEADER 05222nam a22005175i 4500
001 978-94-007-7675-3
003 DE-He213
005 20210619204835.0
007 cr nn 008mamaa
008 170531s2017 ne | s |||| 0|eng d
020 |a 9789400776753  |9 978-94-007-7675-3 
024 7 |a 10.1007/978-94-007-7675-3  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Biomarkers in Liver Disease  |h [electronic resource] /  |c edited by Vinood B. Patel, Victor R. Preedy. 
250 |a 1st ed. 2017. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2017. 
300 |a 162 illus., 110 illus. in color. eReference.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Biomarkers in Disease: Methods, Discoveries and Applications,  |x 2542-3657 
505 0 |a Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease.-Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers.-Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinical applications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease. 
520 |a There are numerous types of liver disease that may be due to toxic agents (such as alcohol or drugs), infectious agents including viruses, congenital conditions and even poor dietary patterns. It has been suggested that there are over 100 different types.  As the consequences of liver failure can be devastating it is important that appropriate diagnosis and monitoring is carried out. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Liver Disease embraces a holistic approach by combining detailed information on different conditions that affect the liver and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry. 
650 0 |a Cancer research. 
650 0 |a Oncology  . 
650 0 |a Pharmacology. 
650 1 4 |a Cancer Research.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B11001 
650 2 4 |a Oncology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160 
650 2 4 |a Pharmacology/Toxicology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B21007 
700 1 |a Patel, Vinood B.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Preedy, Victor R.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eReference 
776 0 8 |i Printed edition:  |z 9789400776760 
776 0 8 |i Printed edition:  |z 9789400776746 
830 0 |a Biomarkers in Disease: Methods, Discoveries and Applications,  |x 2542-3657 
856 4 0 |u https://doi.org/10.1007/978-94-007-7675-3 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXRB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Reference Module Biomedical and Life Sciences (SpringerNature-43744)